Medical Oncology Prof. Dr. Ersin Özaslan
✓ Medically verified profileProf. Dr. Ersin Özaslan
✓ Medically verified profile
About Prof. Dr. Ersin Özaslan
Quick answer
Prof. Dr. Ersin Özaslan is a Medical Oncology specialist at Acibadem Kayseri Hospital in Kayseri with 10+ years of experience.
He treats colorectal cancer, metastatic colorectal cancer, metastatic renal cell carcinoma, gastroenteropancreatic neuroendocrine tumors, metastatic breast cancer, triple-negative breast cancer, liver metastases, and chemotherapy-induced mucositis and leukopenia, and handles treatments including cetuximab plus FOLFOX, FOLFOX chemotherapy, bevacizumab-based chemotherapy, sunitinib, and capecitabine therapy. He consults in Turkish and English and offers online video…
Prof. Ersin Özaslan is a medical oncologist with a solid academic and clinical background. He earned his medical degree from Erciyes University Faculty of Medicine in 2016 and has since focused his career on oncology practice and patient care. In 2018 he joined Acibadem Health Group, where he has been involved in delivering evidence-based cancer treatments and collaborating with multidisciplinary teams to improve outcomes for patients.
Known for a patient-centered approach, Prof. Özaslan combines clinical expertise with clear communication to guide patients and families through diagnosis, treatment options, and follow-up care. He remains committed to ongoing professional development and contributes to the oncology community through clinical work and education.
Areas of Expertise
Conditions treated and procedures performed by this specialist.
Education
- 2016Erciyes University Faculty of Medicine Medical Oncology
- 2012Erciyes University Faculty of Medicine Internal Medicine
- 2007Istanbul University Istanbul Faculty of Medicine
Professional Experience
- 2018Acibadem Health Group
- 2016–2018Kayseri Training and Research Hospital / Medical Oncology
Selected Publications
- Efficacy and safety of cetuximab plus FOLFOX in second-line and third-line therapy in metastatic colorectal cancer Journal of BUON, 22(4), 863-868., (Control No: 3707902) (2017) ÖZASLAN ERSİN,TOPALOĞLU ULA? SERKAN,IMANÇ MEVLÜDE,ERDEM UMUT GÖKMEN,DEMİR HACER,ARPACI ERKAN,?EKER MEHMET METMET METİN,KARAAĞAÇ MUSTAFA,KIZILTEPE MELİH,EKER
- Is sunitinib-induced hypothyroidism a predictive clinical marker for better response in metastatic renal cell carcinoma patients?. JOURNAL OF CHEMOTHERAPY, 28(3), 230-234., Doi: 10.1179/1973947815Y.0000000039., (Control No: 3714951) (2016) BOZKURT OKTAY,KARACA HALİT,HACIBEKİROĞLU İLHAN,KAPLAN MUHAMMED ALİ,DÜZKÖPRÜ YAKUP,UYSAL MÜKREMİN,BERK VELİ,İNANÇ MEVLÜDE,DURAN AY?E OCAK,ÖZASLAN ERSİN
- Psychological distress and loneliness in caregiver of advanced oncological inpatients. Journal of Health Psychology, 21(9), 1896-1906., Doi: 10.1177/1359105314567770, (Control No: 3714548) (2016) SOYLU CEM,ÖZASLAN ERSİN,KARACA HALİT,ÖZKAN METİN
- Evaluation of the concordance between the stage of the disease and Ki-67 proliferation index in gastroenteropancreatic neuroendocrine tumors. EUROPEAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 28(7), 836-841., Doi: 10.1097/MEG.0000000000000619., (2016) (Control No: 3708071) ÖZASLAN ERSİN,DEMİR SİNAN,KARACA HALİT,GÜVEN KADRİ
- Hepatic steatosis is associated with higher incidence of liver metastasis in patients with metastatic breast cancer an observational clinical study JOURNAL OF BUON, 20(4), 963-969., (Control No: 3714005) (2015) DURAN AY?E OCAK,YILDIRIM AFRA,İNANÇ MEVLÜDE,KARACA HALİT,BERK VELİ,BOZKURT OKTAY,ÖZASLAN ERSİN,UÇAR MAHMUT,ÖZKAN METİN
- Predictive Significance of VEGF and HIF-1? Expression in Patients with Metastatic Colorectal Cancer Receiving Chemotherapy Combinations with Bevacizum ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 16(14), 6149-6154., Doi: 10.7314/APJCP.2015.16.14.6149, (Control No: 3714044) (2015) BERK VELİ,DENİZ KEMAL,BOZKURT OKTAY,ÖZASLAN ERSİN,KARACA HALİT,İNANÇ MEVLÜDE,DURAN AY?E OCAK,ÖZKAN METİN
- Predicting the role of the pretreatment neutrophil to lymphocyte ratio in the survival of early triple-negative breast cancer patients. JOURNAL OF BUON, 20(6), 1432-1439., (Control No: 3713937) (2015) BOZKURT OKTAY,KARACA HALİT,BERK VELİ,İNANÇ MEVLÜDE,DURAN AY?E OCAK,ÖZASLAN ERSİN,UÇAR MAHMUT,ÖZKAN METİN
- Is Late Recurrence a Predictive Clinical Marker for Better Sunitinib Response in Metastatic Renal Cell Carcinoma Patients? CLINICAL GENITOURINARY CANCER, 13(6), 548-554., Doi: 10.1016/j.clgc.2015.07.005, (Control No: 3714914) (2015) BOZKURT OKTAY,HACIBEKİROĞLU İLHAN,KAPLAN MUHAMMED ALİ,DÜZKÖPRÜ YAKUP,UYSAL MÜKREMİN,KARACA HALİT,BERK VELİ,İNANÇ MEVLÜDE,DURAN AY?E OCAK,ÖZASLAN ERSİN
- Positive effects of oral ?-glucan on mucocytis and leukopenia in colorectal cancer patients receiving adjuvant FOLFOX-4 combination chemotherapy ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 15(8), 3641-3644., Doi: 10.7314/APJCP.2014.15.8.3641, (Control No: 3714556) (2014) KARACA HALİT,BOZKURT OKTAY,ÖZASLAN ERSİN,BALDANE SÜLEYMAN,BERK VELİ,İNANÇ MEVLÜDE,DURAN AY?E OCAK,DİKİLTA? MUSTAFA,ER ÖZLEM,ÖZKAN METİN
- Lack of prognostic value of mean corpuscular volume with capecitabine therapy in metastatic breast cancer ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 15(6), 2501-2504., Doi: 10.7314/APJCP.2014.15.6.2501, (Control No: 3714566) (2014) BOZKURT OKTAY,BERK VELİ,KAPLAN MUHAMMED ALİ,ÇETİN BÜLENT,ÖZASLAN ERSİN,KARACA HALİT,İNANÇ MEVLÜDE,DURAN AY?E OCAK,ÖZKAN METİN
Frequently Asked Questions
What is Dr. Ersin Özaslan's specialty?
Which hospital does Dr. Ersin Özaslan practise at?
What languages can I use when consulting Dr. Ersin Özaslan?
How can I book an appointment with Dr. Ersin Özaslan?
Is an online video consultation available with Dr. Ersin Özaslan?
How many years of experience does Dr. Ersin Özaslan have?
Can international patients arrange treatment with Dr. Ersin Özaslan?
How do I get a second opinion involving Dr. Ersin Özaslan?
A dedicated team, from first message to follow-up
Our international patient office coordinates your appointment, travel and treatment at JCI-accredited Acıbadem hospitals — and stays with you in your own language, every step of the way.
Schedule your appointment with Prof. Dr. Ersin Özaslan
Choose a date and time that suits you. Our international patient team will check availability and confirm your appointment — usually within 24 hours.
- 1Choose your date & timePick a preferred day and time slot for your visit.
- 2Share your detailsTell us how to reach you and anything we should know.
- 3We confirm with youOur team confirms the appointment by phone or email.
Request your appointment
This request goes directly to this doctor’s schedule.
Your information stays strictly confidential and is used only to arrange your care.
